AdvanSix Inc.

AI-generated fair value estimate for this company.

Method: 10-year two-stage unlevered FCF DCF: normalized FCF base of $50M (a mid-cycle estimate below the current capex-elevated, margin-compressed trailing figure of -$25.8M, and below FY2025's +$6.4M, reflecting AdvanSix's guided 2026 capex reduction to $75-95M from $116M); 2% growth years 1-5, 1.5% years 6-10, reflecting its mature, cyclical, agriculture-exposed end markets; 10% discount rate for leverage and cyclicality; 2% terminal growth; $416.7M net debt ($423.9M debt less $7.2M cash) subtracted; 27.00M shares outstanding.

Reasoning: AdvanSix's trailing free cash flow is currently depressed by a real cyclical downturn in its Plant Nutrients fertilizer segment and elevated growth capex, so cash flow was normalized toward a more sustainable mid-cycle level rather than extrapolating either the current trough or the prior peak.